Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Sprout Pharmaceuticals, Inc
Sprout Pharmaceuticals, Inc
Industry · 13 registered clinical trials.
Status
Trial
Phase
Started
Completed
Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
Sexual Dysfunctions, Psychological
Phase 1
2010-07-01
Terminated
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
Sexual Dysfunctions, Psychological
Phase 3
2010-04-01
Terminated
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and
Sexual Dysfunctions, Psychological, Depression
Phase 3
2010-01-01
Terminated
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
Sexual Dysfunctions, Psychological
Phase 3
2010-01-01
Completed
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Sexual Dysfunctions, Psychological
Phase 3
2009-10-01
Completed
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Diso
Sexual Dysfunctions, Psychological
Phase 3
2009-10-01
Completed
Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder
Sexual Dysfunctions, Psychological
Phase 3
2008-01-01
Completed
Flibanserin Versus Placebo in Premenopausal Women With HSDD
Sexual Dysfunctions, Psychological
Phase 3
2007-06-01
Terminated
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (H
Sexual Dysfunctions, Psychological
Phase 3
2007-02-01
Completed
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
Sexual Dysfunctions, Psychological
Phase 3
2006-07-01
Completed
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desir
Sexual Dysfunctions, Psychological
Phase 3
2006-07-01
Completed
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Sexual Dysfunctions, Psychological
Phase 3
2006-07-01
Completed
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
Sexual Dysfunctions, Psychological
Phase 3
2006-01-01